Preq1-Dihydrochloride

CAS No. 86694-45-3

Preq1-Dihydrochloride( pre-queuosine1 Dihydrochloride )

Catalog No. M24872 CAS No. 86694-45-3

Preq1-Dihydrochloride is an intermediate of the queuosine pathway, it binds with high affinity to the aptamer of PreQ1 riboswitch, which attenuates protein expression.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 85 In Stock
10MG 122 In Stock
25MG 208 In Stock
50MG 303 In Stock
100MG 452 In Stock
200MG Get Quote In Stock
500MG 986 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Preq1-Dihydrochloride
  • Note
    Research use only, not for human use.
  • Brief Description
    Preq1-Dihydrochloride is an intermediate of the queuosine pathway, it binds with high affinity to the aptamer of PreQ1 riboswitch, which attenuates protein expression.
  • Description
    Preq1-Dihydrochloride is an intermediate of the queuosine pathway, it binds with high affinity to the aptamer of PreQ1 riboswitch, which attenuates protein expression.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    pre-queuosine1 Dihydrochloride
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    86694-45-3
  • Formula Weight
    252.1
  • Molecular Formula
    C7H11Cl2N5O
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:5 mM
  • SMILES
    C1=C(C2=C(N1)N=C(NC2=O)N)CN.Cl.Cl
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Vlack E V , Topp S , Seeliger J C , et al. Characterization of Engineered PreQ1 Riboswitches for Inducible Gene Regulation in Mycobacteria[J]. Journal of Bacteriology, 2017, 199(6):e00656-16.
molnova catalog
related products
  • Methylcobalamin

    Methylcobalamin a cobalamin, is a form of vitamin B12.

  • Fondaparinux sodium

    Fondaparinux Sodium is an antithrombin-dependent factor Xa inhibitor with antithrombotic activity.

  • Pelgifatamab

    Pelgifatamab (BAY-2315497) is a prostate-specific membrane antigen (PSMA) antibody with potential anticancer activity that can be used to study prostate cancer.